{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:44:41Z","timestamp":1790714681460,"version":"4.1.0"},"publisher-location":"Berlin, Heidelberg","reference-count":19,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783662550113","type":"print"},{"value":"9783662550120","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/8904_2016_528","type":"book-chapter","created":{"date-parts":[[2016,4,11]],"date-time":"2016-04-11T08:58:10Z","timestamp":1460365090000},"page":"93-97","source":"Crossref","is-referenced-by-count":17,"title":["Missed Newborn Screening Case of Carnitine Palmitoyltransferase-II Deficiency"],"prefix":"10.1007","author":[{"given":"Andrew C.","family":"Edmondson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Salant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne A.","family":"Ierardi-Curto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Ficicioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,12]]},"reference":[{"key":"528_CR1","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.mam.2004.06.004","volume":"25","author":"JP Bonnefont","year":"2004","unstructured":"Bonnefont JP, Djouadi F, Prip-Buus C, Gobin S, Munnich A, Bastin J (2004) Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects. Mol Aspects Med 25:495\u2013520","journal-title":"Mol Aspects Med"},{"key":"528_CR2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1056\/NEJMra0801327","volume":"361","author":"X Bosch","year":"2009","unstructured":"Bosch X, Poch E, Grau JM (2009) Rhabdomyolysis and acute kidney injury. N Engl J Med 361:62\u201372","journal-title":"N Engl J Med"},{"key":"528_CR3","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1136\/archdischild-2014-307663","volume":"100","author":"EK Chan","year":"2015","unstructured":"Chan EK, Kornberg AJ, Ryan MM (2015) A diagnostic approach to recurrent myalgia and rhabdomyolysis in children. Arch Dis Child 100:793\u2013797","journal-title":"Arch Dis Child"},{"key":"528_CR4","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ymgme.2013.04.008","volume":"110","author":"MG Sain-van der Velden de","year":"2013","unstructured":"de Sain-van der Velden MG, Diekman EF, Jans JJ et al (2013) Differences between acylcarnitine profiles in plasma and bloodspots. Mol Genet Metab 110:116\u2013121","journal-title":"Mol Genet Metab"},{"key":"528_CR5","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jpeds.2009.10.031","volume":"156","author":"C Ficicioglu","year":"2010","unstructured":"Ficicioglu C, Coughlin CR 2nd, Bennett MJ, Yudkoff M (2010) Very long-chain acyl-CoA dehydrogenase deficiency in a patient with normal newborn screening by tandem mass spectrometry. J Pediatr 156:492\u2013494","journal-title":"J Pediatr"},{"key":"528_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1023\/A:1015109127986","volume":"25","author":"K Gempel","year":"2002","unstructured":"Gempel K, Kiechl S, Hofmann S et al (2002) Screening for carnitine palmitoyltransferase II deficiency by tandem mass spectrometry. J Inherit Metab Dis 25:17\u201327","journal-title":"J Inherit Metab Dis"},{"key":"528_CR19","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/gim.2014.62","volume":"16","author":"PL Hall","year":"2014","unstructured":"Hall PL, Marquardt G, McHugh DMS et al (2014) Post-analytical tools improve performance of newborn screening by tandem mass spectrometry. Genet Med 16:889\u2013895","journal-title":"Genet Med"},{"key":"528_CR6","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1002\/ajmg.a.32545","volume":"146A","author":"S Illsinger","year":"2008","unstructured":"Illsinger S, L\u00fccke T, Peter M et al (2008) Carnitine-palmitoyltransferase 2 deficiency: novel mutations and relevance of newborn screening. Am J Med Genet A 146A:2925\u20132928","journal-title":"Am J Med Genet A"},{"key":"528_CR7","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1007\/s10545-007-0642-7","volume":"30","author":"H Kobayashi","year":"2007","unstructured":"Kobayashi H, Hasegawa Y, Endo M, Purevsuren J, Yamaguchi S (2007) A retrospective ESI-MS\/MS analysis of newborn blood spots from 18 symptomatic patients with organic acid and fatty acid oxidation disorders diagnosed either in infancy or in childhood. J Inherit Metab Dis 30:606","journal-title":"J Inherit Metab Dis"},{"key":"528_CR8","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1542\/peds.2006-1352","volume":"118","author":"R Mannix","year":"2006","unstructured":"Mannix R, Tan ML, Wright R, Baskin M (2006) Acute pediatric rhabdomyolysis: causes and rates of renal failure. Pediatrics 118:2119\u20132125","journal-title":"Pediatrics"},{"issue":"7","key":"528_CR9","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/gim.2012.2","volume":"14","author":"G Marquardt","year":"2012","unstructured":"Marquardt G, Currier R, McHugh DM et al (2012) Enhanced interpretation of newborn screening results without analyte cutoff values. Genet Med 14(7):648\u2013655","journal-title":"Genet Med"},{"key":"528_CR10","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/GIM.0b013e31820d5e67","volume":"13","author":"D McHugh","year":"2011","unstructured":"McHugh D, Cameron CA, Abdenur JE et al (2011) Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative project. Genet Med 13:230\u2013254","journal-title":"Genet Med"},{"key":"528_CR11","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jpeds.2010.09.026","volume":"158","author":"I Sahai","year":"2011","unstructured":"Sahai I, Bailey JC, Eaton RB, Zytkovicz T, Harris DJ (2011) A near-miss: very long chain acyl-CoA dehydrogenase deficiency with normal primary markers in the initial well-timed newborn screening specimen. J Pediatr 158:172, author reply 172\u2013173","journal-title":"J Pediatr"},{"key":"528_CR12","first-page":"907","volume":"65","author":"JM Sauret","year":"2002","unstructured":"Sauret JM, Marinides G, Wang GK (2002) Rhabdomyolysis. Am Fam Physician 65:907\u2013912","journal-title":"Am Fam Physician"},{"key":"528_CR13","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jpeds.2006.02.037","volume":"149","author":"I Schymik","year":"2006","unstructured":"Schymik I, Liebig M, Mueller M et al (2006) Pitfalls of neonatal screening for very-long-chain acyl-CoA dehydrogenase deficiency using tandem mass spectrometry. J Pediatr 149:128\u2013130","journal-title":"J Pediatr"},{"key":"528_CR14","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1007\/s001340100985","volume":"27","author":"KH Smolle","year":"2001","unstructured":"Smolle KH, Kaufmann P, Gasser R (2001) Recurrent rhabdomyolysis and acute respiratory failure due to carnitine palmityltransferase deficiency. Intensive Care Med 27:1235","journal-title":"Intensive Care Med"},{"key":"528_CR15","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0960-8966(99)00096-6","volume":"10","author":"L Thuillier","year":"2000","unstructured":"Thuillier L, Sevin C, Demaugre F et al (2000) Genotype\/phenotype correlation in carnitine palmitoyl transferase II deficiency: lessons from a compound heterozygous patient. Neuromuscul Disord 10:200\u2013205","journal-title":"Neuromuscul Disord"},{"key":"528_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ymgme.2015.06.006","volume":"116","author":"J Vockley","year":"2015","unstructured":"Vockley J, Marsden D, McCracken E et al (2015) Long-term major clinical outcomes in patients with long chain fatty acid oxidation disorders before and after transition to triheptanoin treatment-A retrospective chart review. Mol Genet Metab 116:53\u201360","journal-title":"Mol Genet Metab"},{"key":"528_CR17","doi-asserted-by":"publisher","first-page":"12S","DOI":"10.1097\/01.gim.0000223467.60151.02","volume":"8","author":"MS Watson","year":"2006","unstructured":"Watson MS, Mann MY, Lloyd-Puryear MA et al (2006) Newborn screening: toward a uniform screening panel and system. Genet Med 8:12S\u2013252S","journal-title":"Genet Med"}],"updated-by":[{"DOI":"10.1007\/8904_2017_587","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,4,14]],"date-time":"2017-04-14T00:00:00Z","timestamp":1492128000000}}],"container-title":["JIMD Reports","JIMD Reports, Volume 33"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/8904_2016_528","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T19:50:55Z","timestamp":1559418655000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/8904_2016_528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9783662550113","9783662550120"],"references-count":19,"URL":"https:\/\/doi.org\/10.1007\/8904_2016_528","relation":{"erratum":[{"id-type":"doi","id":"10.1007\/8904_2017_587","asserted-by":"object"}]},"ISSN":["2192-8304","2192-8312"],"issn-type":[{"value":"2192-8304","type":"print"},{"value":"2192-8312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}